Announced Thu, 25 Jun · 08:30 IST
Non-promoter Manubhai Shah sells 2.75% stake in Bacil Pharma via open market
Ownership Changes View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-1.6%1-day move
₹41.85
prior close
₹41.50
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+2.1+0.1-0.3+0.5-1.6-5.4-4.9-4.4-4.5-9.4-12.8-36.0——
Up moveDown movePending
AI summary
Manubhai Amrutlal Shah, a non-promoter shareholder of Bacil Pharma, sold 3,94,893 equity shares (2.75%) through open market on 23 and 24 June 2026. His holding fell from 18,31,709 shares (12.77%) to 14,36,816 shares (10.02%). The disclosure was filed under SEBI SAST Regulation 29(2).
Likely market impact
Non-promoter trimming stake near 10% threshold; could signal portfolio rebalancing and mild near-term supply pressure on the stock.